MicroPort Scientific : Grant of Share Options

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

微創醫療科學有限公司 *

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 00853) GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The board (the "Board") of directors (the "Director(s)") of MicroPort Scientific Corporation (the "Company") offered to grant an aggregate of 23,340,000 share options (the "Share Option(s)") to eligible participants (the "Grantees"), subject to the acceptance of the Grantees, to subscribe for up to an aggregate of 23,340,000 ordinary shares of the Company (the "Share(s)") of US$0.00001 each in the share capital of the Company under the share option scheme adopted by the Company on 3 September 2010.

Details of the Share Options granted are as follows:

Date of grant : 23 January 2017

Number of the Share Options granted : an aggregate of 23,340,000 Share Options,

each Share Option entitling the holder of the Share Option to subscribe for one Share at the exercise price

Exercise price of the Share Options granted : HK$5.628 per Share Closing price of the Shares on the date of grant : HK$5.45 per Share

The average closing price of the Shares for the five trading days immediately preceding the date of grant

: HK$5.628 per Share

Validity period of the Share Options : 10 years from the date of grant (i.e. 23 January

2017 to 22 January 2027 (both days inclusive))

Vesting period of the Share Options : (i) 500,000 Share Options

100,000 Share Options shall be vested twelve months after the date of grant, and 100,000 additional Share Options shall be vested on each anniversary of the vesting commencement date thereafter

(ii) 22,840,000 Share Options

all the 22,840,000 Share Options shall be vested on the fifth anniversary of the date of grant (i.e. 23 January 2022)

Consideration for the grant : US$1.00 to be paid by each of the Grantees upon acceptance of the Share Options granted

Among the Grantees, Dr. Zhaohua Chang, Chairman and Chief Executive Officer of the Company, was granted a total of 13,500,000 Share Options with an validity period of 10 years.

To the best knowledge and belief of the Board, save as disclosed above, none of the Grantees is a director, chief executive or substantial shareholder of the Company, nor an associate (as defined under the Listing Rules) of any of them. In accordance with the Rule 17.04(1) of the Listing Rules, the grant of the Share Options to Dr. Zhaohua Chang has been approved by the independent non-executive Directors.

By order of the Board

MicroPort Scientific Corporation Dr. Zhaohua Chang

Chairman

Shanghai, the People's Republic of China, 23 January 2017

As at the date of this announcement, the executive Director is Dr. Zhaohua Chang; the non-executive Directors are Mr. Norihiro Ashida, Mr. Hiroshi Shirafuj, Ms. Janine Junyuan Feng and Ms. Weiwei Chen; and the independent non-executive Directors are Mr. Jonathan H. Chou, Dr. Guoen Liu and Mr. Chunyang Shao.

* for identification purpose only